IB
IBRX
ImmunityBio, Inc.
$8.37
1M +9.4%
3M +17.9%
YTD +314.4%
as of 2026-09-14
+Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Weak window historically
Next 30 days (to Oct 15): -4.5% median,
30% of the last 10 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 83
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.40%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.60 -0.7% · Seasonal tilt (10y) -0.4%
$67M/day volume
105% volatility
+223% 1-year
-82% from ATH
52-week range · 61% of the way up · -33% from the high
$1.95$12.43
Congressional trades in IBRX
Full tracker →
1 member · 0 buys / 1 sells
· $1K–$15K disclosed · latest filing Apr 17, 2023.
| SELL |
DG Daniel Goldman
· traded Mar 6, 2023 |
$1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.